The Ethical Review Committee (ERC), or the Human Subject Protection Committee, functions as an Institutional Review Board (IRB) for “Dasman Diabetes Institute (DDI). It is charged to review the ethical aspect of all research proposals that involve Human Subjects, which will be undertaken by the DDI investigators.
The ERC is responsible for ensuring the Dasman Diabetes Institute’s compliance with national and international regulatory standards for research on Human Subjects. National regulatory standards include the laws of the State of Kuwait, rules and regulations of the Ministry of Health, and policies and guidelines of the Dasman Diabetes Institute. In order to ensure compliance with international ethical standards, the Committee evaluates research protocols in accordance with the:
Nuremberg Code of Ethics
Belmont Report- Ethical Principles and Guidelines for the Protection of Human Subjects
World Medical Association Declaration of Helsinki- Ethical Principles for Medical Research Involving Human Subjects
The Committee also takes guidance from applicable international ethical guidelines for biomedical research, such as the International Conference on Harmonization (ICH) guidelines for Good Clinical Practice (GCP) and the Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines for Biomedical Research involving Human Subject and Epidemiological Studies.
“Autonomy, Beneficence, and Justice”
Dr. Abdullah Bennakhi – Dasman Diabetes Institute
Mr. Wajee Imam- Legal Advisor
Dr. Abdulrahman Abdulla Alali- Community Member
Dr. Waleed Al-Dahi- Ministry of Health
Dr. Majedah Abdul Rasoul- Pediatrician, Kuwait University
Dr. Suhail Ahmed- Professor, Faculty of Medicine, Kuwait University
Ms. Rashmi Shiju- Dasman Diabetes Institute (Member and Rapporteur)